We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eli Lilly’s Fourth Quarter Profits Hurt by Zyprexa Settlement
Eli Lilly’s Fourth Quarter Profits Hurt by Zyprexa Settlement
January 31, 2007
Eli Lilly’s profits took a hit in the fourth quarter of 2006, dropping 81 percent due to a nearly $500 million product liability settlement involving its antipsychotic Zyprexa.